Constellation Pharmaceuticals Current Cash

Constellation Pharmaceuticals (CNST) currently reports a current cash of $110M as of March 2021. That compares with $190M in the prior-year period — down 40.2% year over year. Use the charts on this page to explore Constellation Pharmaceuticals's current cash history and peer comparisons.

Constellation Pharmaceuticals's current cash decreased from $190M to $110M — a 40.2% year-over-year decrease (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Constellation Pharmaceuticals reported $110M in current cash as of March 2021. That compares with $190M in the prior-year period — down 40.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Constellation Pharmaceuticals, and consider following CNST for alerts when major investors trade the stock.

Constellation Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNST with unrelated industries.